We have augmented our previous studies [Storey, Shears, Kirk & Michell (1984) Nature (London) 312, 374-376] on the subcellular location and properties ofIns(l ,4,5)P3 (inositol 1,4,5-trisphosphate) phosphatases in rat liver and human erythrocytes. We also investigate Ins(1,3,4)P3 (inositol 1,3,4-trisphosphate) metabolism by rat liver. Membrane-bound and cytosolic Ins(1,4,5)P3 phosphatases both attack the 5-phosphate. The membrane-bound enzyme is located on the inner face of the plasma membrane, and there is little or no activity associated with Golgi apparatus. Cytosolic Ins(1,4,5)P3 5-phosphatase (Mr 77000) was separated by gel filtration from Ins(1,4)P2 (inositol 1,4-bisphosphate) and inositol 1-phosphate phosphatases (Mr 54000). Ins(1,4,5)P3 5-phosphatase activity in hepatocytes was unaffected by treatment of the cells with insulin, vasopressin, glucagon or dibutyryl cyclic AMP. Ins(1,4,5)P3 5-phosphatase activity in cell homogenates was unaffected by changes in [Ca2+] from 0.1 to 2 /LM. After centrifugation of a liver homogenate at 100000 g, Ins(1,3,4)P3 phosphatase activity was largely confined to the supernatant. The sum of the activities in the supernatant and the pellet exceeded that in the original homogenate. When these fractions were recombined, Ins(1,3,4)P3 phosphatase activity was restored to that observed in unfractionated homogenate. Ins(1,3,4)P3 was produced from Ins(1,3,4,5)P4 (inositol 1,3,4,5-tetrakisphosphate) and was metabolized to a novel InsP2 that was the 3,4-isomer. Ins(1,3,4)P3 phosphatase activity was not changed by 50 mM-Li+ or 0.07 mMIns(1,4)P2 alone, but when added together these agents inhibited Ins(1,3,4)P3 metabolism. In Li+-treated and vasopressin-stimulated hepatocytes, Ins(1,4)P2 may reach concentrations sufficient to inhibit Ins(1 ,3,4)P3 metabolism, with little effect on Ins(1,4,5)P3 hydrolysis.
Ins(1,3,4)P3 phosphatase activity was largely confined to the supernatant. The sum of the activities in the supernatant and the pellet exceeded that in the original homogenate. When these fractions were recombined, Ins(1,3,4)P3 phosphatase activity was restored to that observed in unfractionated homogenate. Ins(1,3,4)P3 was produced from Ins(1,3,4,5)P4 (inositol 1,3,4,5-tetrakisphosphate) and was metabolized to a novel InsP2 that was the 3,4-isomer. Ins(1,3,4)P3 phosphatase activity was not changed by 50 mM-Li+ or 0.07 mMIns(1,4)P2 alone, but when added together these agents inhibited Ins(1,3,4)P3 metabolism. In Li+-treated and vasopressin-stimulated hepatocytes, Ins(1,4)P2 may reach concentrations sufficient to inhibit Ins(1 ,3,4)P3 metabolism, with little effect on Ins(1,4,5)P3 hydrolysis.
INTRODUCnION
Inositol lipid hydrolysis is a widespread mechanism of receptor-coupled transmembrane signalling (reviewed by Michell et al., 1981; Berridge, 1984;  Nishizuka, 1984; Downes & Michell, 1985) . After cell stimulation, the hydrolysis of Ptdlns(4,5)P2 leads to the rapid accumulation of Ins(1,4,5)P3, which mobilizes Ca2+ from intracellular stores (reviewed by Berridge & Irvine, 1984) . Ins(1, 4, 5) P3 can be dephosphorylated to Ins(1,4)P2 by a 5-phosphatase that is present in plasma membranes and cytosol Seyfred et al., 1984; Storey et al., 1984; Joseph & Williams, 1985; Connolly et al., 1985; Sasaguri et al., 1985; Erneux et al., 1986; Kukita et al., 1986) . Since Ins(1,4)P2 does not mobilize Ca2+, the hydrolysis of the 5-phosphate of Ins(1,4,5)P3 deactivates the second messenger. It is therefore important to understand the factors which affect the activity of the 5-phosphatase in vivo.
We have studied the Ins(1,4,5)P3 5-phosphatase activity of human erythrocytes and rat liver. The plasma membranes of the former tissue are a convenient source of the enzyme (Downes & Michell, 198 1; Downes et al., 1982) . In liver, we have been particularly concerned with the possibility that the phosphatase may be regulated after receptor activation. We have also attempted to relate our findings to studies of Ins(1,4,5)P3 metabolism in intact hepatocytes (Thomas et al., 1984; Burgess et al., 1985; Palmer et al., 1986; Hansen et al., 1986) .
The interpretation of these studies has been complicated by the identification of a second pathway of Ins(1,4,5)P3 metabolism. This involves its phosphorylation to Ins(1, 3, 4, 5) P4, at least in rat brain and parotid gland Irvine et al., 1986a; Downes et al., 1986 ). An InsP4 which was presumed to be Ins(1,3,4,5)P4 has also been detected in liver Palmer et al., 1986) and pancreas . The Ins(1,3,4,5)P4 is dephosphorylated to Ins(l,3,4)P3 Hansen et al., 1986; Hawkins et al., 1986) . This metabolic pathway accounts for the accumulation of Ins(1,3,4)P3 in a variety of stimulated cells Batty et al., 1985; Burgess et al., 1985; Hansen et al., 1986; Hawkins et al., 1986; Palmer et al., 1986; Turk et al., 1986 ). Although it is not known whether Ins(1,3,4)P3 has any second-messenger activity, it is clearly important in the process by which Ins(1,4,5)P3 is returned to the free inositol pool. We have therefore studied Ins(1,3,4)P3 degradation by liver.
Some of these data have been reported in preliminary form (Shears et al., 1985; Kirk et al., 1987) .
MATERIALS AND METHODS Preparation and incubation of hepatocytes
Hepatocytes were prepared as described by Shears & Kirk (1984a) , with the following modifications. The flow rate during the perfusion was maintained at 25 ml/min, and the medium did not contain Tes. The hepatocytes were suspended at approx. 20 mg dry wt./ml in Krebs bicarbonate-buffered media (Krebs & Henseleit, 1932) , supplemented with 1.25 mM-CaCl2, 10 mM-glucose and 2% (w/v) bovine serum albumin. The incubations were gassed every 15 min with 02/CO2 (19: 1) Studies on the effects of hormones on Ins(1,4,5)P3 5-phosphatase were performed by first adding the agonists to hepatocyte incubations for an appropriate time. Then EGTA was added to a final concentration of 2 mm, and 0.5 ml samples were immediately frozen and stored in liquid N2. These samples were subsequently thawed in 2 ml of 0.25 M-sucrose/5 mM-Tris/HCl, pH 8.0, and then homogenized for 10 s with a Polytron homogenizer on setting 5. Samples (100,ul) were then immediately assayed for Ins(1,4,5)P3 5-phosphatase activity in 1 ml of assay buffer (see below). This procedure diluted the original hepatocyte incubations 55-fold, so the free [Mg2+] and [Ca2+] in the assay medium were not significantly changed by addition of the sample. Preparation of liver homogenates and soluble and particulate fractions
The liver of a male rat (220 g) was perfused during diethyl ether anaesthesia with ice-cold 0.25 M-sucrose/ 5 mM-Tes (pH 7.2). Remaining procedures were performed at 0-4 'C. The liver was homogenized , filtered through gauze and made up to a 30% (w/v) suspension with 0.25 M-sucrose/5 mM-Tes (pH 7.2).
Homogenates were stored on ice until assayed (usually < 1.5 h). Portions of the homogenate (25 ml) were sometimes centrifuged at 100000 g for 1 h. The resultant supernatant and pellet were both made up to 25 ml with more 0.25 M-sucrose/5 mM-Tes in order to ensure that their dilution, relative to the original tissue, was similar to that of the homogenate. Preparation of Golgi-rich vesicles
The liver of a male rat (200 g) was perfused during ether anaesthesia with ice-cold 0.25 M-sucrose to remove the blood. Golgi-rich vesicles were prepared by the method of Morre (1971) , except that, after the preparation was removed from the interface of the discontinuous sucrose-density gradient, it was washed twice with 0.25 M-sucrose (Kuhn & White, 1977) . Enzyme markers Galactosyltransferase (EC 2.4.1.22) was assayed as described by Kuhn & White (1977) , except that incubations were terminated with EDTA and reaction products were separated on anion-exchange columns (borate form) (Bretz & Staubli, 1977) . Alkaline phosphodiesterase 1 (EC 3.1.4.1) wasasa ased as described by Razzel (1963) . Glycogen phosphorylase (EC 2.4.1.1) was assayed as described by Shears & Kirk (1984b) .
Measurement of InsP3 hydrolysis
The incubation medium was slightly modified from that previously described . It contained 70 mM-potassium glutamate, 30 mM-KCl, 10 mM-NaCl, 24 mM-MgSO4 (4 mm free Mg2+),0.33 mMCaCl2 (0.1 Mm free Ca2+), 1 mM-EGTA, 10 mM-Hepes, pH 7.2, and saponin (0.2 mg/ml). No InsP4 was formed from InsP3 in this medium, because ATP was absent (results not shown; and see Irvine et al., 1986a) . Dithiothreitol, which was reported to stimulate Ins(1 ,4,5)P3 5-phosphatase activity (Seyfred et al., 1984) , was without effect in our assays (results not shown) and was therefore not included in the incubation medium. For some experiments the free [Ca2+] was altered by changing total [Ca2+] . The media for these studies were prepared at pH 7.2 +0.005 and 37°C by using a Corning 150 pH-meter. The following apparent association constants were used: Ca2+-EGTA, 6.898 x 106, and Mg2+-EGTA, 93.7 (Burgess et al., 1983); Ca2+-glutamate, 26.92, and Mg2+-glutamate, 97.72 (Campbell, 1983 . Alternatively, the disappearance of [4,5-32P]Ins-(1,4,5)P3 and/or appearance of both [4-32P] Ins(1,4)P2 and [32P]P1 was measured. In these experiments, incubations were terminated with 0.2 ml of 1.7 M-HCI04. The precipitated protein was removed by centrifugation and the supernatants were neutralized as described by Bone et al. (1984) , except that 60 mM-EDTA was included in the neutralization medium, to prevent the precipitation of Mg2+ salts of InsP3. After anionexchange chromatography of the neutralized extracts, [32P]Pi, [4-32P]Ins(l, 4)P2 and [4,5-32P]Ins(1,4,5)P3 were sequentially eluted in 20 ml fractions . Radioactivity in these fractions was determined from their lerenkov radiation.
Hydrolysis (Palmer et al., 1986) . This fraction was freeze-dried . The Ins(l,4,5)P3 was then removed by incubating the extract with human erythrocyte membranes (5 mg of protein/ml; for 2 h in 2 ml of 20 mM-Hepes (pH 7.0)/5 mM-MgCl2 containing 0.2 mg of saponin/ml. The reaction was terminated with 0.8 ml of 2 M-HC104, and an InsP3 fraction (containing approx. 200000 d.p.m. of 3H) was eluted and freeze-dried as described above. The final preparation was taken up in 1 ml of water and stored in batches at -20 'C. The InsP3 was analysed by h.p.l.c. (see below) and eluted as a single peak with the expected mobility of Ins(1,3,4)P3 (see, e.g., Fig. 4 ). The chemical quantity of Ins(l,3,4)P3 produced by this method was estimated to be about 1.8 nmol, assuming that vasopressin-stimulated and Li+-treated hepatocytes produce 60 pmol of [3H]InsP3/mg cell dry wt. (Thomas et al., 1984) , ofwhich 75% was assumed to be Ins(l ,3,4)P3 . Since 5S 1 of the final preparation (in 1 ml) was usually added to 0.5 ml incubations for the assay of Ins(1,3,4)P3 phosphatase activity, the initial Ins(1,3,4)P3 concentration therein would be about 18 nm.
[3H]InsP4 and [4,5-32P]InsP4 were respectively prepared by ATP-dependent phosphorylation , 1982) . The InsP3 was incubated at 37 'C with 2% (v/v) of a 100000 g rat liver supernatant in 0.5 ml of medium containing 0.25 M-sucrose, 50 mM-Tes (pH 7.5) 20 mM-MgCl2, 10 mM-ATP, 25 mM-2,3-bisphosphoglycerate (Na+ salt) and saponin (0.2 mg/ml). After 15 min (for incubations containing 32p) or 45 min (for incubations with 3H), reactions were terminated with 0.2 ml of 1.7 M-HCIO4. After neutralization (see above), the InsP4 was purified by anion-exchange chromatography and freeze-dried . Samples were taken up in 1 ml of water and stored in batches at -20 'C. In both preparations, about 50% of the starting InsP3 was recovered as InsP4.
Some batches of [3H]
InsP3 yielded less InsP4, apparently because of batch variation in specific radioactivity, which affected the InsP3 concentration in our medium (nominally 2 /M, and close to the Km for the kinase of 0.6 lsM; see Irvine et al., 1986) . Percentage yields were restored when only 0.5,Ci of [3H]InsP3 was added. We have assumed that our preparations of InsP4 are the 1,3,4,5 isomer, as in brain and parotid glands Downes et al., 1986; Irvine et al., 1986a) . Consistent with this assumption, the InsP4 was eluted as a single peak on h.p.l.c. with the expected mobility of Ins(1,3,4,5)P4 (results not shown).
[4-32P]Ins(1,4)P2 was prepared by 5-phosphatase hydrolysis of [4,5-32P]Ins(1,4,5)P3 and freeze-dried . Non-radioactive Ins(1,4)P2 was generously supplied by Dr. R. Irvine. Preparation of soluble Ins(1,4,5)P3 phosphatase
The liver of a male rat (250 g) was perfused with ice-cold 0.25 M-sucrose/5 mM-Tris/HCl, pH 7.4, under pentobarbitone anaesthesia. Once cleared of blood, the liver was homogenized in an equal volume of 0.25 Msucrose/5 mM-Tris/HCl, pH 7.4, filtered and centrifuged at 0-4 0C for 1 h at 180000g. The supernatant was concentrated about 3-fold by using Amicon Centricon-lO micro-concentrators, and 1 ml of the resultant preparation was applied to a column (75 cm x 4 cm) of Sephadex G-l00 equilibrated with 20 mM-maleate/5 mM-Tris/HCl, pH 7.2, and eluted with the same medium at a flow rate of 0.2 ml/min. The column was calibrated with carbonic anhydrase, creatine kinase and bovine serum albumin (Mr 81000, 66000 and 29000 respectively).
Separation of inositol phosphates by h.p.l.c.
Incubations to be analysed by h.p.l.c. were terminated with 0.2 ml of ice-cold 1.7 M-HC104. Samples were then prepared, at 0-4°C, by a slight modification of a method in turn derived from that of Sharpes & McCarl (1982) . The tissue pellets were removed by centrifugation for 5 min at 1000 g. Then 0.65 ml of the supernatant was added to 1 ml of 1,1,2-trichlorotrifluoroethane/tri-n-octylamine (1: 1, v/v). After vigorous mixing, samples were centrifuged for 5 min at 1000g. Next, 0.4 ml of the upper aqueous phase was removed, and replaced with 0.4 ml of water. The mixing and centrifugation were repeated, and 0.4 ml of the aqueous layer was removed. The combined aqueous samples were filtered (0.45 gm filters, Gelman Sciences Ltd., Northampton, U.K.) and loaded, via a 1 ml injection loop, on to a 25 cm x 0.46 cm main column plus 5 cm x 0.46 cm guard column, both containing Whatman Partisil 10-SAX. Elution began with water, for 5 min, and then exactly followed the protocol of Batty et al. (1985) , at a flow rate of 1.25 ml/min. The 'dead' time in our apparatus was 2.5 min (i.e. the time between injection of [3H]inositol and its appearance in the fractions; Fig. 4 ). Fractions (1 ml) were collected for the first 10 min, and 0.5 ml of each of these was added to 5 ml of scintillant (see above). For the remainder of the elution period 0.25 ml fractions were collected. These were dissolved in 1 ml of water/methanol (1: 1, v/v) (see Hawkins et al., 1986) , followed by 4 ml of scintillant (see above). Switzerland) . The CaCl2 used for the Ca2+/EGTA buffers was made by adding HCI to CaCO3. 1,1,2-Trichlorotrifluoroethane and tri-n-octylamine were purchased from Aldrich Chemical Co. (Gillingham, Dorset, U.K.).
RESULTS AND DISCUSSION
Properties of the Ins(1,4,5)P3 5-phosphatase of the plasma membrane
In our previous studies of the Ins(1,4,5)P3 5-phosphatase from erythrocytes , assays were performed in a dilute buffer (30 mmHepes/2 mM-MgCl2). In recognition of the probable regulatory importance of this enzyme, we changed to the routine use of a medium that more closely resembles cell cytosol (see the Materials and methods section). When erythrocyte membranes were incubated in the medium of nearer-physiological ionic strength, the first-order rate constant for Ins(1,4,5)P3 hydrolysis was 60 + 4% (n = 4) of that observed in the more dilute medium. Therefore, those workers who have used low-ionic-strength media (Seyfred et al., 1984; Connolly et al., 1985; Erneux et al., 1986) may have overestimated the physiological activity of the 5-phosphatase.
Our preparations of [4,5-32P]Ins(1 ,4,5)P3 (see the Materials and methods section) contained a greater proportion of 32P in the 5-phosphate than in the 4-phosphate. When the 5-phosphate alone was removed from a batch of [4,5-32P]Ins(1,4,5)P3 by incubating it with erythrocyte membranes , the ratio for the distribution of 32p label in the products, [32P]Pi: [4-32P]Ins(1,4)P2, was 2.4: 1 (n = 2). Liver plasma membranes (prepared as described by Storey et al., 1984) were incubated with the same batch of unevenly labelled [4,5-32P]Ins(1,4,5)P3. During 15 min incubations there was no significant hydrolysis of the InsP2 produced, and the 32P label was distributed between the products
[32P]Pi and [32P]InsP2 in the ratio 2.5:1 (n = 2). Therefore the InsP2 can only be the 1,4-isomer, confirming that the Ins(1,4,5)P3 phosphatase of liver plasma membranes specifically attacks the 5-phosphate. Two other reports (Seyfred et al., 1984; Joseph & Williams, 1985) In a previous study we showed that approximately three-quarters of the hepatic Ins(1,4,5)P3 5-phosphatase activity was membrane-bound, and the remainder was cytosolic. We also separated liver fractions on Percoll density gradients, and Ins(1,4,5)P3 5-phosphatase was associated with markers for plasma membranes, but not with markers for lysosomes, endoplasmic reticulum or mitochondria . However, in these experiments we did not separate plasma membranes from Golgi membranes. Two other groups of workers (Seyfred et al., 1984; Joseph & Williams, 1985) also showed that Ins(1,4,5)P3 5-phosphatase co-purified with markers for plasma membranes, but not for endoplasmic reticulum or mitochondria. Hence it has not previously been shown to what extent the Golgi apparatus can dephosphorylate Ins(1,4,5)P3. We have now resolved this uncertainty by purifying a Golgi-rich fraction from rat liver. This fraction showed an 86-fold purification of a Golgi marker (galactosyltransferase) relative to the homogenate (Table 1) . However, the enrichment of Ins(1,4,5)P3 5-phosphatase in the Golgi fractions was only 4.3-fold, which is of the same order as the 2.7-fold enrichment of the plasma-membrane marker alkaline phosphodiesterase 1. The data in Table 1 demonstrate that there was little Ins(1,4,5)P3 5-phosphatase activity in Golgi vesicles.
We have measured Ins(1,4,5)P3 5-phosphatase activity on the inner and outer faces of tightly resealed erythrocyte membranes. The efficiency of resealing in these experiments was confirmed by the almost complete latency of the Ca2+/calmodulin-activated Ca2+-ATPase, an enzyme with its active site on the cytoplasmic face of the membrane (results not shown; and see . The Ins(1,4,5)P3 5-phosphatase activity of these resealed membranes was very low, and was activated 70-fold by small quantities of saponin (Fig. 1) . It thus appears that virtually all of the Ins(1,4,5)P3 5-phosphatase activity in erythrocyte membranes is at the cytoplasmic surface. Since Ins(1,4,5)P3 is largely retained The Ins(1,4,5)P3 5-phosphatase activity was assayed by measuring [32P]Pj release. The specific radioactivity of Ins(l,4,5)P3 was calculated as previously described (Fig. 2) . The apparent Mr values of the last two enzymes were about 54000, whereas that of the Ins(1,4,5)P3 phosphatase was 77000. In contrast, Connolly et al. (1985) reported that the cytosolic Ins(1,4,5)P3 5-phosphatase from platelets had an Mr of 38000. This apparent difference may indicate that this enzyme can exist in a multimeric form. Alternatively, the Ins(1,4,5)P3 5-phosphatases of these two cell types may be quite distinct.
A preparation of soluble Ins(1,4,5)P3 phosphatase freed of Ins(1,4)P2 phosphatase (as in Fig. 2) (since it was different from that used in the study of the 5-phosphatase of liver plasma membranes described above) was also incubated with erythrocyte membranes to remove the 5-phosphate . Further assays, on samples taken from incubations of hepatocytes treated with 230 nM-vasopressin for 2 min, demonstrated that glycogen phosphorylase activity was 3.7 + 0.5-fold (n = 4) greater than in control samples. This stimulation is of a similar magnitude to that observed in our previous experiments (Shears & Kirk, 1984b) , indicating that these cells responded normally to vasopressin.
The cytosolic [Ca2+] in unstimulated rat hepatocytes is about 0.16 /SM and increased to about 1.3 #M during maximal stimulation with agonists (Berthon et al., 1984; Thomas et al., 1984) . Table 2 shows that increasing the [Ca2+] in our assay medium from 0.1 uM up to 2 /M did not affect Ins(1,4,5)P3 5-phosphatase activity (even if 10 l,g of calmodulin/ml was also added; results not shown). These experiments suggest that the Ins(1,4,5)P3 5-phosphatase of liver is not regulated by hormonal mobilization of Ca2 . In contrast, Ins(1,4,5)P3 5-phosphatase activity in pig smooth muscle (Sasaguri et al., 1985) and guinea-pig macrophages (Kukita et al., 1986) of hydrolysis was half that observed for Ins(1,4,5)P3 hydrolysis by similar dilutions of liver homogenate . Ins(1,3,4)P3 metabolism was also studied in incubations containing 100000 g soluble and particulate fractions of liver. These fractions were adjusted to their concentration in the original homogenates (see the Materials and methods section). Ins(1,3,4)P3 phosphatase activity predominated in the supernatant fraction, and there was much less activity in the particulate fraction (Fig. 3a) . Although in some experiments the soluble Ins(1,3,4)P3 phosphatase activity exceeded that ofthe original homogenate, overall this was not a statistically significant phenomenon. Nevertheless, the total activity of the particulate and soluble fractions always exceeded that of the original homogenate (Fig.  3a) . Therefore, the Ins(1,3,4)P3 phosphatase activity must be activated in some way during the separation of the particulate and soluble fractions. When these fractions were recombined, this apparent activation was reversed, and the total Ins(1,3,4)P3 phosphatase activity was restored to that in the unfractionated homogenate (Fig. 3b) . We do not know whether this reversible activation of Ins(1,3,4)P3 phosphatase represents a mechanism of physiological significance.
Products of Ins(1,3,4)P3 metabolism
The 3H-labelled products of [3H]Ins(1,3,4)P3 metabolism were separated, by h.p.l.c., into three fractions (Fig.  4) . The first two fractions had the expected mobilities of Ins and InsP respectively. In samples taken from incubations terminated at 10 min (results not shown) and 20 min (Fig. 4b) , no 3H-labelled product co-chromatographed with authentic Ins(1,4)P2. However, a 3H-labelled compound, which was presumably another isomer of InsP2, was eluted 0.6 min after Ins(1,4)P2.
In principle, the novel InsP2 could be Ins(3,4)P2 or Ins(1,3)P2, or a mixture of both. Other studies, with liver ) and parotid glands ), have also demonstrated that the major 3H-labelled product of Ins(1,3,4)P3 hydrolysis is not Ins(1,4)P2. Hansen et al. (1986) suggested that the novel isomer was Ins(1,3)P2, but reported no results to justify this proposal.
We further analysed the novel InsP2 isomer derived from Ins(1,3,4)P3 by studying the simultaneous dephosphorylation of Hawkins et al., 1986; Hansen et al. 1986 ). This finding was checked in our experiments after first determining that the 32p label in the [4,5-32P]Ins(1,3,4,5)P4 was distributed between the 5-and 4-phosphates in the ratio 71 +0.5: 29+0.6 (n = 4). This of the InsP3 product was 28-31 % of that for Ins(1,3,4,5)P4. Note that any significantly larger value for the 32P/3H ratio of the InsP3 fraction would have demonstrated that at least one of the products of Ins(1,3,4,5)P4 degradation retained the highly labelled 5-phosphate. After 10 min incubations with liver homogenate, the InsP2 product retained the same 32P: 3H ratio as the Ins(1,3,4)P3 (Table 3) , so the InsP2 must quantitatively retain the 32P-labelled 4-phosphate. Since Ins(1,4)P2 is not produced by Ins(1,3,4)P3 hydrolysis (Fig. 4) , the product that accumulates must be Ins(3,4)P2. The slight decrease in the 32p: 3H ratio of the InsP2 fraction after 20 min incubations (Table 3) , which might suggest a small accumulation of Ins(1,3)P2, was not statistically significant.
The Ins(3,4)P2 can be separated from Ins(1,4)P2 by h.p.l.c. (Fig. 4b) . Therefore, if 3H-labelled inositol phosphates in stimulated cells were to be analysed by h.p.l.c., more than one InsP2 peak might be detected. This pattern has been observed in experiments on a pituitary cell line (Heslop et al., 1985) , pancreas ) and liver . The last two groups of workers speculated that Ins(1,3)P2 was the later-eluted and rather smaller of the two InsP2 peaks. Our experiments indicate that, at least in liver, the two isomers probably correspond to Ins(1,4)P2, produced from Ins(1,4,5)P3, and Ins(3,4)P2, derived from Ins(1,3,4)P3.
The 32P: 3H ratio of the 'InsP+ Pi' fraction was much larger than that of the other fractions in Table 3 In stimulated cells, the concentrations of InsP and InsP2 are increased by treatment with Li+ (Berridge et al., 1982; Thomas et al., 1984; Palmer et al., 1986) , which inhibits InsIP and Ins(1,4)P2 phosphatases (Hallcher & Sherman, 1980; Berridge et al., 1982; Storey et al., 1984) . Li+ neither potentiates the agonist-mediated accumulation of Ins(1,4,5)P3 (Burgess et al., 1985; Hansen et al., 1986) nor inhibits Ins(1,4,5)P3 5-phosphatase (Seyfred et al., 1984; Storey et al., 1984; Joseph & Williams, 1985;  13HIIns(1,3,4,5)P4 and 14,5-32PIIns(1,3,4,5 (Table 4) . We do not understand why our result is different from that of Hansen et al. (1986) . The Ins(1,4,5)P3 5-phosphatase prepared from platelets was inhibited by 0.1 mM-Ins(1,4)P2 (Connolly et al., 1985) , but 0.4 mM-Ins(1,4)P2 did not inhibit Ins(1,4,5)P3 hydrolysis by erythrocyte membranes . We studied the effect of 0.07 mM-Ins(1,4)P2 on hydr6lysis of both Ins(1,4,5)P3 and Ins(1,3,4)P3, in both the presence and the absence of 50 mM-Li+. This concentration of Ins(1,4)P2 is within the range of concentrations that we have estimated to occur in Li+-treated and maximally stimulated liver cells. Under such conditions, [Ins(1,4)P2] may range between 0.03 and (Burgess et al., 1984; Thomas et al., 1984; Hansen et al., 1986; Palmer et al., 1986) . Although 0.07 mM-Ins(1,4)P2 alone may have slightly inhibited the dephosphorylation of Ins(1,4,5)P3 and Ins(1,3,4)P3, these effects did not achieve statistical significance (Table 4) . However, in these incubations the concentration of Ins(1,4)P2 would have decreased rapidly, owing to its dephosphorylation . When Ins(1,4)P2 hydrolysis was greatly decreased by including 50 mM-Li+ in the incubations (see Storey et al., 1984) , the metabolism of both InsP3 isomers was inhibited significantly (Table 4 ). The effect on Ins(1,3,4)P3 hydrolysis was considerably greater than that on Ins(1,4,5)P3 metabolism, although a precise quantitative comparison is not possible because of the unspecified kinetic properties of Ins(1,3,4)P3 phosphatase. Nevertheless, the data in Table 4 may explain how Li+, by potentiating an accumulation of Ins(1,4)P2 in stimulated cells, thereby increases the concentration of Ins(1,3,4)P3 more significantly than that ofIns(1,4,5)P3 (Burgess et al., 1985; Hansen et al., 1986) .
Concluding comments
Ins(l,4,5)P3 is an intracellular messenger, and it is to be expected that its metabolism, like that of cyclic AMP (Heyworth et al., 1983) , will be subject to physiological control. An understanding of such control will require a knowledge both of the enzymes responsible and of their susceptibility to regulation. The activity of the kinase which converts Ins(1,4,5)P3 into Ins(1,3,4,5)P4 was inhibited 2-3-fold as [Ca2+] was changed from 0.1 to 10gM . Ins(1,4,5)P3 is also metabolized by removal of the 5-phosphate (see above, and the Introduction) and, at least in liver, we have been unable to show regulation of this reaction (Table 2) The more we learn of inositol polyphosphate metabolism in mammalian cells, the more complex becomes the famity of-enzymes involved in the many observed reactions (Michell, 1986) . It must be assumed that this has, for reasons, which we are only beginning to understand, been-an evolutionarily worthwhile investment of genomic capacity and protein synthesis. Since many of the inositol polyphosphates are only subtly different, we may expect that many of these enzymes will be structurally and evolutionarily related.
Note added in proof (received 9 December 1986) Recent work has indicated that Ins(1,3,4)P3 mobilizes intracellular Ca2+ in S-wiss-mouse 3T3 cells (Irvine et al., 1986b) w-hereas Ins(1,3,4,5)P4 facilitates Ca2+ influx into sea-urchin eggs (Irvine & Moor, 1986 
